Metromedia Bio-Sciences

Metromedia Bio-Science was a biotechnology company founded by billionaire John Kluge to develop and commercialize D-tagatose, a rare sugar with therapeutic potential for metabolic disorders. The company focused on the clinical development of D-tagatose as a treatment for Type 2 diabetes and obesity, leveraging its unique properties as a low-calorie sweetener that improves glycemic control. Through partnerships with Spherix and Arla Foods, the company successfully obtained GRAS status for D-tagatose in the United States, allowing its use in food and beverages. Although the company is no longer active in drug development, its work laid the foundation for the use of rare sugars in managing metabolic health.